Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

A unique comparative study of five vaccines in EU member Hungary on 3.7 million people shows Sputnik V is the best vaccine to protect against mortality from COVID with 98% efficacy and 85.7% efficacy against infection

Press release, 25.11.2021

RDIF announces major Sputnik V efficacy data from San Marino, an upcoming registration of the Sputnik M vaccine and reiterates vaccine combos are the key to fight the pandemic

Press release, 24.11.2021

Sputnik V shows 80% long-term efficacy against COVID in San Marino from 6th through 8th month after administering the second dose

Press release, 24.11.2021

The single-component Sputnik Light vaccine authorized in Laos

Press release, 23.11.2021

The one-shot Sputnik Light vaccine authorized in San Marino

Press release, 23.11.2021

A study in Belarus on Sputnik V shows high safety profile and 96.3% efficacy against COVID after vaccination of over 1.2 million people

Press release, 17.11.2021

A study published in The Lancet confirms the one-shot Sputnik Light vaccine has a high safety profile and induces a strong humoral and cellular immune response both in the seronegative and seropositive groups

Press release, 03.11.2021

A study in the city of Buenos Aires confirms high efficacy of the Sputnik V in protecting individuals aged 60+

Press release, 01.11.2021

Sputnik V and Sputnik Light vaccines authorized in Cambodia

Press release, 31.10.2021

Individuals vaccinated with Sputnik V in Argentina are now eligible to enter EU

Press release, 29.10.2021

1 2 3 4 5